Status:
COMPLETED
Innovations in Treating COPD Exacerbations: Pilot Project on Action Plans Using New Technology.
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
COPD
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The purpose of this project is to conduct a pilot study evaluating the feasibility and potential benefits of a phone assessment/reporting system (tele-system) in addition to a written action plan and ...
Detailed Description
BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is the 4th leading cause of death in Canada and the only chronic disease where mortality rates continue to climb. Acute exacerbations are commo...
Eligibility Criteria
Inclusion
- Patients will be adults with COPD at high risk for exacerbations
- Post bronchodilator spirometry FEV1 \<80% pred. and FEV1/FVC \<0.70
- Aged ≥ 40 yrs
- Smoking ≥ 10 pack-years
- 1 or more exacerbations requiring antibiotic or prednisone in the last year. (This is the population with the highest chance of having another exacerbation
- Combination therapy LABA-ICS (Advair) with or without an anticholinergic (Spiriva or Atrovent) and a rescue SABA (Ventolin)
Exclusion
- Combination therapy LABA-ICS other than Advair
- Home oxygen for 18-24 hours/day
- Chronic CO2 retention
- Previous NIMV/MV
- Cognitive impairment
- Does not speak English or French fluently
- Severe co-morbidities such as bronchiectasis with recurrent infections, severe left congestive heart failure
- Survival \<6 months
- Any significant medical condition other than COPD that may also result in dyspnea (e.g. unstable angina, BMI \> 40).
Key Trial Info
Start Date :
October 15 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 29 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02275078
Start Date
October 15 2013
End Date
November 29 2017
Last Update
August 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal Chest Institute
Montreal, Quebec, Canada, H2X2P4